Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition
Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75
Read More
Factual Version of a Story
U.S. drugmaker